Texas Cannabis Companies File Competing Lawsuits Over THC Sales Rights

The Legal Battle Lines

Hemp retailers and medical marijuana operators have filed dueling lawsuits in Texas courts, each claiming the other is operating outside state law. The cases represent the first major courtroom clash between the two cannabis industry segments since Texas lawmakers expanded the state's medical program in 2023.

At issue is whether hemp-derived delta-8 THC and similar cannabinoids fall under the state's 2019 hemp law or whether they constitute controlled substances that can only be sold by licensed medical dispensaries. The distinction carries enormous financial stakes. Texas has nearly 30 million residents and no adult-use cannabis program.

What Each Side Claims

Medical marijuana license holders argue that hemp retailers are selling intoxicating THC products without the regulatory oversight required under the Compassionate Use Program. The licensed operators contend that any product intended for intoxication should fall under medical cannabis rules, regardless of its source plant.

Hemp retailers counter that their products are explicitly legal under Texas House Bill 1325, which legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC. They argue the law doesn't restrict other cannabinoids like delta-8 THC, THCA, or HHC.

These competing interpretations have created a regulatory gray zone that's allowed hemp shops to proliferate across Texas while medical dispensaries operate under strict licensing caps and product restrictions.

The cleanest read on this dispute is that Texas lawmakers never anticipated the hemp industry would engineer intoxicating products that technically comply with the 2019 statute.

Market Control at Stake

The outcome will determine whether Texas maintains a tightly controlled medical market or allows a largely unregulated hemp-THC retail sector to continue expanding. Medical marijuana license holders have invested millions in compliance infrastructure, laboratory testing, and security systems required under state law. Hemp retailers face no comparable requirements.

Key differences between the two markets include:

• Medical dispensaries serve only registered patients with qualifying conditions
• Hemp shops sell to any adult without medical documentation
• Medical products are capped at 1% THC; hemp-derived products have no potency limits beyond the delta-9 threshold
• Medical operators pay substantial licensing fees; hemp retailers operate under general business licenses

Industry analysts estimate the Texas hemp-THC market generated over $500 million in sales in 2025, while the medical program served fewer than 50,000 registered patients.

For full background on this story, see the CannIntel topic hub on the Texas THC legal battle.

The lawsuits arrive as the Texas Department of State Health Services has declined to issue formal guidance on hemp-derived intoxicants. That's left enforcement to local district attorneys who've taken inconsistent positions across the state's 254 counties.